genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Artificial Intelligence
Putting COVID-19 on the ‘Map’
GEN Edge
Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths
Patenting/Legal
Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies
GEN Edge
Top 15 Best-Selling Drugs of 2019
News
News
Hereditary Gene Defect Found to be Most Common Cause of Childhood…
Neuroscience
Autism Gender Bias Explained in Some Cases by Single Amino Acid…
Coronavirus
COVID-19 Vaccine Progress in Pittsburgh
Genetics
Personalized Medicine Approach May Extend Polygenic Scores to Individuals with Multiple…
Coronavirus
COVID-19 Testing Gets the Green-Light from Color Genomics
Insights
All
Trends for 2020
Commentary
Understanding Glycans in COVID-19 Drug Design
Coronavirus
NYC Scientists Swab the Subway in Search of SARS-CoV-2
Artificial Intelligence
Artificial Intelligence Is Helping Biotech Get Real
April 2020 Vol. 40 No.4
Cell-Based Immunotherapies Do Battle With Solid Tumors
A-Lists
Gilead Sciences
Catching Up to Coronavirus: Top 60 Treatments in Development
GEN Edge
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Insights
Top 10 Life Sciences Jobs Most in Demand over the Next…
GEN Edge
Ten Life Science Analysts to Watch in 2020
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Hereditary Gene Defect Found to be Most Common Cause of Childhood…
Neuroscience
Autism Gender Bias Explained in Some Cases by Single Amino Acid…
Coronavirus
COVID-19 Vaccine Progress in Pittsburgh
GEN Edge
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Magazine
March 2020 Vol. 40 No. 3
Expanding the CRISPR Toolbox
Commentary
Strategies for Optimizing CRISPR-Cas9 Delivery into Hard-to-Transfect Cells
March 2020 Vol. 40 No. 3
RNA Silencing Finds Its Therapeutic Voice
March 2020 Vol. 40 No. 3
Genomic Medicine Identifies Reconcilable Differences
Commentary
Hasten Genomic Medicine’s Rise with Advanced Data Management
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Feel the Flow: Immune Cell Signaling Cascades Reveal Phenotype and Function
April 2020 Vol. 40 No.4
A New Lease on Life for shRNA
April 2020 Vol. 40 No.4
To Improve Protein Aggregation Assessments, Combine PCT and MMS
April 2020 Vol. 40 No.4
Protein Labeling Kit
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Patenting/Legal
Patenting/Legal
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Patenting/Legal
Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies
Patenting/Legal
Rejecting Broad Institute Opposition, EPO Affirms CRISPR Patent Issued to Charpentier, UC, and U. Vienna
Patenting/Legal
HHS Sues Gilead, Contending HIV Drugs Infringe on Agency Patents
Patenting/Legal
Purdue Pharma Files for Bankruptcy, in Pursuit of $10B Settlement
Patenting/Legal
Eleventh U.S. CRISPR-Cas9 Patent Awarded to University of California, U. Vienna, Charpentier
Patenting/Legal
Broad Institute, UC File Motions Lists in Latest CRISPR Interference Proceeding
Patenting/Legal
Sigma-Aldrich Petitions for Interference Between 3 Applications, UC Patents for CRISPR...
Patenting/Legal
Broad Institute, MilliporeSigma to Offer Non-Exclusive Licenses to CRISPR IP
Patenting/Legal
Interference Declared over CRISPR-Cas9 for Eukaryotic Cells, Reigniting Patent War
Patenting/Legal
Insys Shares Plunge After Warning of Chapter 11 Bankruptcy Filing
Patenting/Legal
Insys Founder, Four Former Executives Convicted of RICO Conspiracy Tied to...
Patenting/Legal
Roche Extends Offer for Spark Therapeutics a Second Time, as Shareholders...
Patenting/Legal
University of California, U. Vienna, Charpentier Awarded Fourth U.S. CRISPR-Cas9 Patent
Patenting/Legal
UC, University of Vienna, Charpentier Granted Third European CRISPR Patent
Patenting/Legal
University of California and Partners Awarded Third U.S. CRISPR-Cas9 Patent
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
